The role of antimicrobial peptides in animal defenses

Proceedings of the National Academy of Sciences of the United States of America - Tập 97 Số 16 - Trang 8856-8861 - 2000
Robert E. W. Hancock1, Monisha G. Scott1
1Department of Microbiology and Immunology, University of British Columbia, Vancouver,BC, Canada V6T 1Z3

Tóm tắt

It is becoming clear that the cationic antimicrobial peptides are an important component of the innate defenses of all species of life. Such peptides can be constitutively expressed or induced by bacteria or their products. The best peptides have good activities vs. a broad range of bacterial strains, including antibiotic-resistant isolates. They kill very rapidly, do not easily select resistant mutants, are synergistic with conventional antibiotics, other peptides, and lysozyme, and are able to kill bacteria in animal models. It is known that bacterial infections, especially when treated with antibiotics, can lead to the release of bacterial products such as lipopolysaccharide (LPS) and lipoteichoic acid, resulting in potentially lethal sepsis. In contrast to antibiotics, the peptides actually prevent cytokine induction by bacterial products in tissue culture and human blood, and they block the onset of sepsis in mouse models of endotoxemia. Consistent with this, transcriptional gene array experiments using a macrophage cell line demonstrated that a model peptide, CEMA, blocks the expression of many genes whose transcription was induced by LPS. The peptides do this in part by blocking LPS interaction with the serum protein LBP. In addition, CEMA itself has a direct effect on macrophage gene expression. Because cationic antimicrobial peptides are induced by LPS and are able to dampen the septic response of animal cells to LPS, we propose that, in addition to their role in direct and lysozyme-assisted killing of microbes, they have a role in feedback regulation of cytokine responses. We are currently developing variant peptides as therapeutics against antibiotic-resistant infections.

Từ khóa


Tài liệu tham khảo

10.1016/S0167-7799(97)01156-6

C Hetru, D Hoffmann, P Bulet Molecular Mechanisms of Immune Responses in Insects, eds P T Brey, D Hultmark (Chapman & Hall, London), pp. 40–66 (1998).

10.1128/AAC.43.6.1317

10.1016/S1357-2725(99)00013-8

10.1073/pnas.93.10.5156

10.1517/13543784.7.2.167

10.1093/jac/42.2.277

10.1016/S1079-2104(99)70131-9

10.1001/archsurg.133.7.715

10.1128/IAI.66.5.1861-1868.1998

10.1128/IAI.67.11.6084-6089.1999

10.1074/jbc.273.44.28978

10.1128/iai.56.3.693-698.1988

10.1074/jbc.271.6.2935

10.1002/jnr.490420515

P Elsbach, J Weiss Inflammation: Basic Principles and Clinical Correlates, eds J I Gallin, I M Goldstein, R Snyderman (Raven, New York), pp. 445–470 (1988).

M Scott, H Yan, R E W Hancock Infect Immun 67, 2006–2009 (1999).

10.1021/bi9826299

10.1021/bi9904104

10.1128/AAC.43.5.1111

10.1021/bi9811617

10.1128/AAC.41.8.1738

10.1128/iai.62.7.2715-2721.1994

10.1128/iai.62.9.3837-3843.1994

M Soell, E Lett, F Holveck, M Scholler, D Wachsmann, J-P Klein J Immunol 154, 851–860 (1995).

10.1128/iai.63.4.1380-1386.1995

10.1073/pnas.92.22.10359

10.1084/jem.188.2.305

H Goto, S Nakamura Jap J Exp Med 50, 35–43 (1980).

10.1006/cyto.1996.0040

10.1128/AAC.42.12.3073

10.1001/archinte.1994.00420010044006

10.1016/S0952-7915(99)80004-1

A L DeFranco, M T Crowley, A Finn, J Hambleton, S L Weinstein Prog Clin Biol Res 397, 119–136 (1998).

10.1074/jbc.273.15.8680

10.1128/iai.65.3.858-864.1997

10.1016/S1369-5274(98)80142-2

10.1016/S1074-7613(00)80119-3

10.1128/iai.64.12.4922-4927.1996

10.4049/jimmunol.164.2.549

10.1016/S0952-7915(98)80030-7

10.1128/IAI.66.2.486-491.1998

10.1128/IAI.67.12.6445-6453.1999

A J Moore, D A Devine, M C Bibby Peptide Res 7, 265–269 (1994).

10.1128/AAC.43.7.1542

10.1002/jlb.66.4.579

10.1021/bi9811617

Thông tin
Thông tin xuất bản

Proceedings of the National Academy of Sciences of the United States of America

Tập 97 Số 16

8856-8861

Thông tin tác giả